Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Odyssey Therapeutics, Inc. (NASDAQ: ODTX)
ODTX Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-32.90%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
85.70%
ODTX Stock Analysis
ODTX
PE Ratio:
ODTX
PEG Ratio:
Not Available
ODTX
Forward EPS Growth (12 month):
0.00%
ODTX
PS Ratio:
252.3
ODTX
PSG Ratio:
Not Available
ODTX
Forward Revenue Growth (12 month):
0.00%
ODTX Articles
No data was found